Research published in Eur J Pharmacol - The Consciousness Library

Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.

Eur J Pharmacol April 9, 2011

Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.

DOI: 10.1016/j.ejphar.2011.03.050

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.

Eur J Pharmacol October 14, 2010

A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.

DOI: 10.1016/j.ejphar.2010.10.012

Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain.

Eur J Pharmacol July 13, 2010

Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain.

DOI: 10.1016/j.ejphar.2010.07.004 Full text

The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behaviour, locomotor activity and ataxia in guinea pig.

Eur J Pharmacol July 1, 1996

The effects of (+)-SKF10047 and ketamine hydrochloride on stereotyped behaviour, locomotor activity and ataxia in guinea pig.

DOI: 10.1016/0014-2999(96)00267-1

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity.

Eur J Pharmacol December 1, 1995

Body temperature effect on methylenedioxymethamphetamine-induced acute decrease in tryptophan hydroxylase activity.

DOI: 10.1016/0926-6917(95)90065-9

Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats.

Eur J Pharmacol July 1, 1995

Methylenedioxymethamphetamine induces opposite changes in central pre- and postsynaptic 5-HT1A receptors in rats.

DOI: 10.1016/0014-2999(95)00303-3

Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine in mice.

Eur J Pharmacol April 1, 1993

Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine in mice.

DOI: 10.1016/0926-6917(93)90057-w

Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.

Eur J Pharmacol September 1, 1992

Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.

DOI: 10.1016/0926-6917(92)90027-a

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

Eur J Pharmacol September 1, 1992

The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.

DOI: 10.1016/0014-2999(92)90743-n

A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.

Eur J Pharmacol November 1, 1991

A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effects on monoamine concentrations in brain dialysates.

DOI: 10.1016/0014-2999(91)90697-o

Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

Eur J Pharmacol 1988

Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens.

DOI: 10.1016/0014-2999(88)90432-3

Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.

Eur J Pharmacol April 1, 1986

Direct comparison of hallucinogenic phenethylamines and D-amphetamine on dorsal raphe neurons.

DOI: 10.1016/0014-2999(86)90420-6

Influence of psychotomimetics and lisuride on synaptosomal dopamine release in the nucleus accumbens of rats.

Eur J Pharmacol September 1, 1983

Influence of psychotomimetics and lisuride on synaptosomal dopamine release in the nucleus accumbens of rats.

DOI: 10.1016/0014-2999(83)90140-1

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

Eur J Pharmacol July 1, 1983

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.

DOI: 10.1016/0014-2999(83)90464-8

Papers